UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000047428
Receipt No. R000054037
Scientific Title The stratified analysis on the preventive and therapeutic effects of increased physical fitness by long termed interval walking training on age-associated diseases in middle-aged and older people
Date of disclosure of the study information 2022/04/11
Last modified on 2022/04/07 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The study on the preventive and therapeutic effects of increased physical fitness by interval walking training on age-associated diseases in middle-aged and older people
Acronym The study on effects of increased physical fitness by interval walking training on age-associated diseases
Scientific Title The stratified analysis on the preventive and therapeutic effects of increased physical fitness by long termed interval walking training on age-associated diseases in middle-aged and older people
Scientific Title:Acronym The stratified analysis on the effects of increased physical fitness by interval walking training on age-associated diseases
Region
Japan

Condition
Condition Age associated diseases
Classification by specialty
Medicine in general Endocrinology and Metabolism Neurology
Psychosomatic Internal Medicine Geriatrics Orthopedics
Anesthesiology Laboratory medicine Rehabilitation medicine
Adult
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 To examine the preventive and therapeutic effects of increased physical fitness by interval walking training for 5 months on age-associated diseases in middle-aged and older people
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The maximal aerobic capacity before and after interval walking training for 5 months.
Key secondary outcomes Age-associated disease symptoms; the symptoms of life-style related diseases (hypertension, hyperglycemia, obesity and dyslipidemia), orthopedic diseases (chronic osteoarthritis and osteoporosis), and psychiatric disorders (insomnia, depression, and dementia)

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Behavior,custom
Interventions/Control_1 Interval walking training
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
40 years-old <=
Age-upper limit
85 years-old >=
Gender Male and Female
Key inclusion criteria 1) Those who can walk independently.
2) Those who have received their home doctors' permission to participate in the study.
3) Those who gave us their informed consents after explained about the details of the study.
Key exclusion criteria 1) Those who do not meet the inclusion criteria.
2) Those who are judged to be inappropriate for participating the study by the lead principal investigator.
Target sample size 2000

Research contact person
Name of lead principal investigator
1st name Shizue
Middle name
Last name Masuki
Organization Shinshu University
Division name Graduate School of Medicine
Zip code 390-8621
Address 3-1-1 Asahi Matsumoto Nagano
TEL 0263372682
Email masuki@shinshu-u.ac.jp

Public contact
Name of contact person
1st name Shizue
Middle name
Last name Masuki
Organization Shinshu University
Division name Graduate School of Medicine
Zip code 390-8621
Address 3-1-1 Asahi Matsumoto Nagano
TEL 0263372682
Homepage URL
Email masuki@shinshu-u.ac.jp

Sponsor
Institute Shinshu University
Institute
Department

Funding Source
Organization Shinshu University
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Shinshu University School of Medicine
Address 3-1-1 Asahi Matsumoto Nagano
Tel 0263372572
Email mdrinri@shinshu-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 04 Month 11 Day

Related information
URL releasing protocol
Publication of results Partially published

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2005 Year 07 Month 05 Day
Date of IRB
2005 Year 07 Month 05 Day
Anticipated trial start date
2005 Year 07 Month 05 Day
Last follow-up date
2027 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2022 Year 04 Month 07 Day
Last modified on
2022 Year 04 Month 07 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054037